International Journal of Scientific Research in Dental and Medical Sciences

International Journal of Scientific Research in Dental and Medical Sciences

Evaluation of the Oncologic Outcomes of Breast Cancer According to the Smooth Implants Versus Textured Implants: A Systematic Review and Meta-analysis

Document Type : Review Article

Authors
1 School of Medicine, Faculdade de Medicina da Universidade do Porto-FMUP, Porto, Portugal
2 Department of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
4 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 Department of Internal Medicine, College of Medicine, University of Iowa, Iowa, United States
Abstract
Background and aim: Concerns about the potential carcinogenic effects of breast implants, particularly those with textured surfaces, have recently been raised by an increasing number of reports of anaplastic large cell lymphoma associated with breast implants. The present study was conducted to evaluate oncologic outcomes of breast cancer according to the smooth implants vs. textured implants.
Material and methods: For this systematic review and meta-analysis study, international databases such as MEDLINE (PubMed and Ovid), Web of Science, and Scopus were searched until July 2024 using keywords relevant to the study objectives. Cohort studies published in English that investigated the oncologic outcomes of breast cancer according to the surface type of implants were included in the study. STATA/MP. v17 software was used to analyze data.
Results: Six studies were reviewed. The use of a textured implant vs smooth implant was associated with a significantly lower DFS (HR, 2.88; 95% CI, 1.71-4.04) vs (HR, 2.96; 95% CI, 1.57-4.35), (p<0.01).
Conclusions: According to the results of the present meta-analysis, breast cancer recurrence may be related to the type of surface implant used for reconstruction.
Keywords

Subjects


[1] Keech Jr JA. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plastic and reconstructive surgery. 1997;100(2):554-5.
[2] Loch-Wilkinson A, Beath KJ, Knight RJ, Wessels WL, Magnusson M, Papadopoulos T, et al. Breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plastic and reconstructive surgery. 2017;140(4):645-54. https://doi.org/10.1097/PRS.0000000000003654.
[3] Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, et al. US epidemiology of breast implant–associated anaplastic large cell lymphoma. Plastic and reconstructive surgery. 2017;139(5):1042-50. https://doi.org/10.1097/PRS.0000000000003282.
[4] Rastogi P, Riordan E, Moon D, Deva AK. Theories of etiopathogenesis of breast implant–associated anaplastic large cell lymphoma. Plastic and reconstructive surgery. 2019;143(3S):23S-9S. https://doi.org/10.1097/PRS.0000000000005566.
[5] Atiyeh B, Emsieh S. Breast implant illness (BII): real syndrome or a social media phenomenon? A narrative review of the literature. Aesthetic Plastic Surgery. 2022:43-57. https://doi.org/10.1007/s00266-021-02428-8.
[6] Tang YB, editor. Breast Reconstruction: Conceptual Evolution. BoD–Books on Demand; 2024.
[7] Lee KT, Kim S, Jeon BJ, Pyon JK, Mun GH, Ryu JM, et al. Association of the implant surface texture used in reconstruction with breast cancer recurrence. JAMA surgery. 2020;155(12):1132-40. https://doi.org/10.1001/jamasurg.2020.4124.
[8] Teughels W, Van Assche N, Sliepen I, Quirynen M. Effect of material characteristics and/or surface topography on biofilm development. Clinical oral implants research. 2006;17(S2):68-81. https://doi.org/10.1111/j.1600-0501.2006.01353.x.
[9] Hussain B, Grytten JI, Rongen G, Sanz M, Haugen HJ. Surface Topography Has Less Influence on Peri-Implantitis than Patient Factors: A Comparative Clinical Study of Two Dental Implant Systems. ACS Biomaterials Science & Engineering. 2024;10(7):4562-74. https://doi.org/10.1021/acsbiomaterials.3c01809.
[10] De Avila ED, Nagay BE, Pereira MM, Barão VA, Pavarina AC, Van Den Beucken JJ. Race for applicable antimicrobial dental implant surfaces to fight biofilm-related disease: advancing in laboratorial studies vs stagnation in clinical application. ACS Biomaterials Science & Engineering. 2022;8(8):3187-98. https://doi.org/10.1021/acsbiomaterials.2c00160.
[11] Danino MA, Nizard N, Paek LS, Govshievich A, Giot JP. Do bacteria and biofilm play a role in double-capsule formation around macrotextured implants?. Plastic and Reconstructive Surgery. 2017;140(5):878-83. https://doi.org/10.1097/PRS.0000000000003767.
[12] Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, et al. Breast implant–associated anaplastic large cell lymphoma: a systematic review. JAMA surgery. 2017;152(12):1161-8. https://doi.org/10.1001/jamasurg.2017.4026.
[13] Salvans S, Mayol X, Alonso S, Messeguer R, Pascual M, Mojal S, et al. Postoperative peritoneal infection enhances migration and invasion capacities of tumor cells in vitro: an insight into the association between anastomotic leak and recurrence after surgery for colorectal cancer. Annals of surgery. 2014;260(5):939-44. https://doi.org/10.1097/SLA.0000000000000958.
[14] Dorcaratto D, Mazzinari G, Fernandez M, Muñoz E, Garcés-Albir M, Ortega J, et al. Impact of postoperative complications on survival and recurrence after resection of colorectal liver metastases: systematic review and meta-analysis. Annals of surgery. 2019;270(6):1018-27. https://doi.org/10.1097/SLA.0000000000003254.
[15] Aoyama T, Murakawa M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, et al. Impact of postoperative complications on survival and recurrence in pancreatic cancer. Anticancer research. 2015;35(4):2401-9.
[16] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj. 2021;372. https://doi.org/10.1136/bmj.n71.
[17] Minozzi S, Cinquini M, Gianola S, Gonzalez-Lorenzo M, Banzi R. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application. Journal of clinical epidemiology. 2020;126:37-44. https://doi.org/10.1016/j.jclinepi.2020.06.015.
[18] Peterson J, Welch V, Losos M, Tugwell PJ. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;2(1):1-2.
[19] Spoor J, Dieleman F, Bleiker EM, Koppert LB, Peeters MJ, Van Leeuwen FE, et al. Recurrence of breast cancer after reconstruction with macro-textured silicone breast implants: A retrospective cohort study. International Journal of Surgery. 2024:10-97. https://doi.org/10.1097/JS9.0000000000001878.
[20] Huang YY, Sacks B, Fahey MT, Farrell G, Poliness C, Webb A. Reviewing the risk of breast cancer recurrence following breast reconstruction. ANZ Journal of Surgery. 2023;93(7-8):1938-43. https://doi.org/10.1111/ans.18520.
[21] Ha JH, Cheun JH, Jung JJ, Kim HK, Lee HB, Shin HC, et al. Impact of implant surface type on breast cancer relapse after breast reconstruction: propensity score-matched study. British Journal of Surgery. 2023;110(10):1288-92. https://doi.org/10.1093/bjs/znad147.
[22] Wu ZY, Han HH, Han J, Son BH, Eom JS, Kim SB, et al. Breast cancer recurrence after smooth versus textured implant-based breast reconstruction: A matched cohort study. Plastic and Reconstructive Surgery. 2022;150:30S-7S. https://doi.org/10.1097/PRS.0000000000009491.
[23] Wu ZY, Han HH, Kim HJ, Lee JW, Chung IY, Kim J, et al. A propensity score-matched comparison of recurrence outcomes after immediate implant vs autologous flap reconstruction in patients receiving neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 2021;187:417-25. https://doi.org/10.1007/s10549-021-06114-w.
[24] Atlan M, Nuti G, Wang H, Decker S, Perry T. Breast implant surface texture impacts host tissue response. Journal of the mechanical behavior of biomedical materials. 2018;88:377-85. https://doi.org/10.1016/j.jmbbm.2018.08.035.
[25] Cole SW. Chronic inflammation and breast cancer recurrence. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2009;27(21):3418. https://doi.org/10.1200%2FJCO.2009.21.9782.
 [26] Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant–associated lymphoma. Plastic and reconstructive surgery. 2015;135(2):319-29. https://doi.org/10.1097/PRS.0000000000000886.
[27] Meza Britez ME, Caballero LLano C, Chaux A. Periprosthetic breast capsules and immunophenotypes of inflammatory cells. European journal of plastic surgery. 2012;35:647-51. https://doi.org/10.1007/s00238-012-0728-9.
[28] Chan SA, Malik F, Wharton S, Klocke R. Systemic inflammatory disease resolution following cosmetic silicone breast implant removal. Case Reports. 2015;2015:bcr2014207418. https://doi.org/10.1136/bcr-2014-207418.
[29] Silva MM, Modolin M, Faintuch J, Yamaguchi CM, Zandona CB, Cintra W, et al. Systemic inflammatory reaction after silicone breast implant. Aesthetic plastic surgery. 2011;35:789-94. https://doi.org/10.1007/s00266-011-9688-x.
 [30] Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology. 2009;27(21):3437-44. https://doi.org/10.1200/JCO.2008.18.9068.
Volume 6, Issue 3
Summer 2024
Pages 134-141

  • Receive Date 06 August 2024
  • Revise Date 04 September 2024
  • Accept Date 07 September 2024
  • Publish Date 10 September 2024